Skip to content Skip to footer

Forum Replies Created

Viewing 15 posts - 271 through 285 (of 445 total)
  • Author
    Posts
  • Understanding the typical timeline can help make sense of why doctors recommend screening and treatment at specific ages, rather than a “wait and watch” approach.

    *Birth through childhood: The gene change is present in every cell from birth, but the colon is usually still clear of polyps, or has only a few scattered ones. This is often when genetic testing is offered to children of an affected parent, specifically to work out who has inherited the gene change and needs to begin screening, and who hasn’t and can be spared unnecessary procedures.
    Early teenage years (roughly age ten to fifteen): Small polyps typically begin to appear in the colon and rectum, initially few and small.
    *Late teens through the twenties: The number of polyps steadily climbs, often reaching into the hundreds or thousands. Individual polyps also begin picking up additional, separate genetic changes over and above the original APC change, which is the same step-by-step process seen in ordinary colon cancer, except here it’s happening in many polyps at once rather than just one.
    *By the late thirties, without treatment: The risk of colon cancer becomes very high, close to certain. With so many polyps present, each with its own independent chance of change, it becomes a statistical near-certainty that at least one will progress to cancer. On average, without treatment, colon cancer is diagnosed around age thirty-nine, decades earlier than typical colon cancer in the general population.
    *The milder (attenuated) type follows the same underlying process, just later: polyps tend to appear in the twenties or thirties, and while cancer risk is still meaningfully higher than average, it tends to develop around a decade or more later than in the classic type.

    This is also why lifelong follow-up matters even after the colon is treated: this condition can affect other parts of the body too. This includes a lifelong, elevated risk of polyps in the upper part of the small intestine (called the duodenum), where doctors use a specific staging system to track how advanced any polyps there are and how often to check; a risk of desmoid tumours, the firm, non-cancerous but locally persistent growths mentioned earlier, occurring in roughly ten to twenty percent of people, often after abdominal surgery; a higher risk of thyroid cancer, particularly in young women; and, rarely, a form of liver tumour that can occur in early childhood, which is why some families are offered simple screening for their infants. Your care team will guide you on exactly which of these apply to your situation.

    The reassuring part of this otherwise serious picture is that this predictable timeline is exactly why this condition is considered highly manageable when caught early. A cancer outcome that would otherwise be near-certain becomes largely avoidable through timely monitoring and treatment.

    In the early stages, this condition usually causes no symptoms at all. The polyps can be present and slowly increasing in number for years before anything is noticeably wrong. This is exactly why family history matters so much as a warning sign; waiting for symptoms to appear often means waiting too long.

    When symptoms do eventually appear, it’s usually because the number of polyps has become substantial. They can include:

    *Blood in the stool, or blood noticed after using the toilet, which may come and go rather than being constant
    *Looser stools, more frequent bowel movements, or mucus in the stool
    *Crampy tummy pain, occasionally caused by a larger polyp temporarily causing part of the bowel to fold into itself
    *Feeling unusually tired, weak, or breathless, which can be a sign of anaemia (low iron levels) caused by slow, ongoing blood loss that isn’t obvious to the eye
    *Losing weight without trying, which tends to be a later sign
    In rare, more advanced cases, feeling a firm lump in the abdomen
    *Occasionally, in children, slower-than-expected growth has been noted as a subtle early clue

    Some people also notice things outside the intestine, which can sometimes appear even before any bowel symptoms and prompt earlier suspicion, especially in families with the Gardner-type presentation:

    *Firm, painless bony bumps on the jaw, forehead, or skull
    *Extra or unerupted teeth found during a routine dental check-up
    *Small, firm skin cysts, often on the scalp, face, or trunk, sometimes appearing in childhood
    *Deep, firm swellings in the abdominal wall (desmoid tumours), sometimes noticed after an unrelated surgery
    *A specific pigmented spot at the back of the eye, harmless in itself, that an eye doctor may notice during a dilated eye examination and that can support the diagnosis in some families

    The main takeaway: if a parent, sibling, or child has been diagnosed with Familial Adenomatous Polyposis, please don’t wait for symptoms to appear before getting checked. Screening should begin based on family history and your doctor’s guidance, not on how you currently feel.

    Familial Adenomatous Polyposis isn’t one-size-fits-all; it can look quite different from person to person, partly depending on exactly where along the APC gene the variant occurs.

    *Classic type: The most common and most intense form. Over one hundred, often thousands, of polyps develop, usually starting in the early teenage years. Without treatment, the risk of colon cancer becomes nearly certain by the late thirties. This form is often linked to gene changes located in the middle portion of the APC gene.
    *Milder (attenuated) type: Fewer polyps, usually under one hundred, tend to appear later, often in the thirties or forties, and tend to cluster more on the right side of the colon. The cancer risk is still significantly higher than average, but it typically develops about ten to fifteen years later than in the classic type. This form is usually linked to gene changes located toward either end of the APC gene.
    *With additional features (sometimes called Gardner Syndrome): Some people with the classic gene change also develop features outside the intestine: harmless bony bumps on the jaw or skull (called osteomas), extra or unerupted teeth noticed at a dental check-up, small skin cysts, and occasionally firm growths in the abdominal wall or abdomen called desmoid tumours, which are non-cancerous but can grow locally and sometimes appear after abdominal surgery. Doctors now understand this isn’t a separate genetic condition, just a different way the same underlying gene change can show up in the body.
    *With brain tumour risk (sometimes called Turcot Syndrome): A rare pattern where a specific type of brain tumour, called medulloblastoma, occurs alongside the intestinal polyps. It’s worth knowing that there is a second, genetically different condition that also carries this same historical name but is linked to an entirely different set of genes and a different brain tumour type, so genetic testing is what distinguishes the two.
    *A related but separate condition (MUTYH-Associated Polyposis): This condition can look almost identical on colonoscopy, with multiple colon polyps, but is caused by changes in a completely different gene called MUTYH, which normally helps repair everyday wear-and-tear damage to the body’s genetic material. Unlike Familial Adenomatous Polyposis, this condition usually requires both parents to carry a gene change for a child to be affected, rather than just one parent. This distinction matters a great deal for counseling siblings and other family members, since the risk pattern for them is different, which is why genetic testing to tell the two conditions apart is so important.

    All these depends on the genetic change found in the patient, emphasising the importance of genetic counseling and genetic testing to plan a treatment, surveillance and screening plan for the patient.

    in reply to: What is Familial Adenomatous Polyposis, and what causes it? #599

    Familial Adenomatous Polyposis is an inherited condition where the large intestine (colon) and rectum develop many small growths called polyps, often starting in the teenage years. On their own, these polyps are not cancer, but over time, one or more of them can slowly develop further changes and turn into colon cancer. This condition is responsible for less than one in every hundred colon cancer cases overall, but it is important to recognise because, unlike most cancers, it is largely preventable once identified early.

    The condition is caused by a change (variant) in a gene called APC. To understand why this matters, it helps to know what this gene normally does: it acts like a quality-control brake on cell growth in the lining of the intestine, helping cells divide at a normal, controlled pace and then stop when they should. When the APC gene isn’t working properly, this brake fails, and cells in the intestinal lining begin dividing faster than they should, eventually forming polyps.

    Here’s an important detail that explains why so many polyps form rather than just one: every cell in the body of a person with this condition already carries one faulty copy of the APC gene from birth. A polyp only starts growing in a particular spot once the second, previously normal copy of the gene in that one cell also stops working, usually due to random wear and tear over time. Because the “first” faulty copy is already present everywhere in the colon, this “second hit” ends up happening independently in many different cells across the colon over the years, which is why hundreds or even thousands of separate polyps can appear, rather than just a single growth.

    Familial Adenomatous Polyposis runs in families. If one parent has it, each of their children, sons and daughters equally, has a fifty percent chance of inheriting it. It doesn’t skip generations. In about one in every four to five people diagnosed, there is no family history at all; the gene change happened for the first time in that person, on its own, this situation the variant is called a de novo. This doesn’t change how the condition is managed for that individual, but it does mean their own children would still have a fifty percent chance of inheriting it going forward. The condition is estimated to affect roughly one in every ten thousand to twenty thousand people worldwide, affecting all ethnic groups equally.

    Genetic factors are estimated to underlie a significant proportion of male infertility cases, particularly in men with very low or absent sperm counts. The main genetic causes include:

    *Klinefelter syndrome: A chromosomal condition in which a man carries an extra X chromosome, most commonly resulting in a 47,XXY karyotype instead of the typical 46,XY. This leads to small, firm testes and, in most cases, absent sperm production due to progressive loss of the cells that produce sperm from early adulthood onward.

    *Y-chromosome microdeletions: Small missing segments within specific regions of the Y chromosome, known as the AZF regions (AZFa, AZFb, and AZFc), which contain genes essential for sperm production. Deletions in AZFa or AZFb are typically associated with complete absence of sperm and very poor prospects for sperm retrieval, while AZFc deletions may still allow some sperm to be retrieved surgically in select cases.

    *CFTR gene mutations: Mutations in the CFTR gene, best known for causing cystic fibrosis, can also cause congenital bilateral absence of the vas deferens, a condition where the tubes that carry sperm from the testes fail to develop. Sperm production may be entirely normal in these men, but sperm cannot reach the ejaculate, making surgical sperm retrieval necessary for biological fatherhood. Men with this finding and their partners require genetic counseling and carrier screening before pursuing assisted reproduction, since a child could inherit two copies of a mutated CFTR gene and develop cystic fibrosis.

    *Other chromosomal translocations and structural rearrangements: Balanced translocations, where segments of chromosomes are rearranged without loss of genetic material, do not usually harm the carrier’s health but can disrupt sperm production or lead to genetically unbalanced sperm, contributing to infertility or recurrent pregnancy loss in the partner.

    *Single-gene mutations: A smaller subset of cases involves mutations in specific genes governing sperm development, structure, or motility, such as genes responsible for sperm tail formation in conditions causing complete sperm immotility. These are less commonly tested for in routine practice but may be relevant in select unexplained cases.

    Identifying a genetic cause changes clinical management in two important ways: it helps predict whether surgical sperm retrieval is likely to succeed, and it determines whether genetic counseling and screening of the partner is needed before assisted reproduction, to assess the risk of passing the condition to offspring. For this reason, genetic testing is recommended for men with sperm counts under five million per millilitre or with no sperm at all in the ejaculate, rather than being reserved only for cases with a strong family history.

    in reply to: What are the different types or causes of male infertility? #590

    Male infertility is broadly classified based on where the problem originates:

    *Pre-testicular causes: Hormonal imbalances originating outside the testes, such as low levels of gonadotropin-releasing hormone, luteinizing hormone, or follicle-stimulating hormone, which disrupt the signals needed for sperm production. Conditions like hypogonadotropic hypogonadism fall here.
    *Testicular causes: Direct problems within the testes affecting sperm production or quality. This includes varicocele (enlarged veins in the scrotum), undescended testes, testicular injury or infection, chromosomal conditions such as Klinefelter syndrome, and certain genetic mutations affecting genes like CFTR or Y-chromosome microdeletions.
    *Post-testicular causes: Sperm are produced normally but cannot be delivered effectively. This includes blockages in the vas deferens or epididymis, absence of the vas deferens (often linked to CFTR gene mutations), retrograde ejaculation, and erectile or ejaculatory dysfunction.
    *Idiopathic male infertility: No identifiable cause is found despite thorough evaluation, which accounts for a notable proportion of cases and may involve subtle genetic, epigenetic, or environmental factors not yet fully understood.

    in reply to: What is male infertility, and how common is it? #589

    Male infertility refers to a man’s inability to cause pregnancy in a fertile female partner despite regular, unprotected intercourse for twelve months or more. It results from problems affecting sperm production, sperm function, or the delivery of sperm during ejaculation. Male factors contribute to nearly half of all infertility cases worldwide, either as the sole cause or alongside a female factor. In India, this is increasingly recognized as a shared concern between partners rather than being attributed to the woman by default, and clinical evaluation of the male partner is now considered a routine first step in any infertility workup.

    Testing is generally recommended after twelve months of trying to conceive without success, or after six months if the age of partners are advanced. However, certain signs warrant earlier evaluation regardless of how long the couple has been trying: a history of undescended testes in childhood, previous testicular surgery or trauma, recurrent respiratory infections (which can point to genetic conditions like cystic fibrosis affecting CFTR), a family history of infertility or genetic conditions, very low sex drive, erectile or ejaculatory difficulties, or a visibly enlarged or twisted scrotal vein suggestive of varicocele. Men with these risk factors should not wait the full year before consulting a specialist.

    in reply to: What are the next steps after a male infertility diagnosis? #586

    Next steps depend entirely on the underlying cause identified:

    *Lifestyle and medical management: For hormonal imbalances, medication can often restore normal sperm production. Lifestyle changes such as quitting smoking, reducing alcohol, managing weight, and avoiding excessive heat exposure to the scrotum may improve semen parameters in mild cases.
    *Surgical correction: Varicocele repair, or surgical correction of blockages in the vas deferens or epididymis, can restore natural fertility in appropriate candidates.
    *Assisted reproductive techniques: When natural conception is unlikely, options include intrauterine insemination, in vitro fertilization, or intracytoplasmic sperm injection, where a single sperm is directly injected into an egg. For men with very low or absent sperm counts, surgical sperm retrieval techniques can extract sperm directly from the testes or epididymis for use in these procedures.
    *Genetic counseling: When a genetic cause such as a chromosomal abnormality or CFTR mutation is identified, genetic counseling is essential before proceeding with assisted reproduction, since some conditions can be passed on to offspring.
    *Donor sperm or adoption: Considered when no viable sperm can be retrieved and other options are not feasible or acceptable to the couple.

    A clinical geneticist or fertility specialist typically coordinates this pathway, ensuring the couple understands both the medical findings and the implications for future children before deciding on a course of treatment.

    in reply to: What counts as a “rare disease,” and how many are there? #585

    A rare disease is typically defined as one affecting a small proportion of the population, though the exact threshold varies by country. There are thousands of known rare diseases, and the majority of them have a genetic basis, even when the exact cause hasn’t been identified yet for a specific patient.

    Yes, to some extent. These are multifactorial conditions, meaning multiple genes combined with lifestyle and environmental factors influence a person’s risk. Genetics doesn’t determine the outcome on its own, but it can affect susceptibility.

    Rare conditions can have overlapping or unusual symptoms that don’t clearly point to one diagnosis, and many doctors may not encounter a particular rare condition often enough to recognize it quickly. This is often called the “diagnostic odyssey,” and broader genetic testing has significantly shortened this journey for many families.

    Some broader panels can look at multiple risk-related genes at once, giving a wider picture of hereditary risk rather than testing for a single condition. This is often discussed as part of a genetic counseling session based on your specific family history.

    Not necessarily. Having a genetic risk factor increases the likelihood compared to the general population, but whether it develops can also depend on other genes, lifestyle, and environment, depending on the specific condition.

    in reply to: What is newborn screening? #568

    Newborn screening is a group of simple tests done on a baby in the first few days after birth to check for certain health conditions that are not visible at birth but could seriously affect the baby’s growth and development if missed. These conditions include some metabolic disorders (where the body cannot process certain foods or nutrients properly), hormonal problems (such as an underactive thyroid gland), certain blood disorders, and hearing loss.

    The testing usually involves three simple steps:

    *A few drops of blood taken from the baby’s heel (this is often called the heel-prick test) and sent to a laboratory
    *A hearing test done using a small, painless device while the baby is asleep or resting
    *A quick check of the baby’s oxygen levels to screen for certain heart conditions

    None of these tests are painful in a lasting way, and none of them require the baby to be sedated or admitted separately. The idea is simple: catch a problem before it causes harm, at a stage when the baby looks and behaves completely normal.

Viewing 15 posts - 271 through 285 (of 445 total)